Photo: Getty Images
Is the singlemindedness of the Biden administration's Covid-19 strategy coming to an end? For the first time since becoming president, Joe Biden mentioned monoclonal treatments in a speech last month. These are drugs that can treat someone infected with Covid-19 and can protect others from the disease when exposed to an infected person. Clinical trials show that Regeneron’s monoclonal antibody treatment, a combination of two antibodies called casirivimab and imdevimab, reduces COVID-19-related hospitalization or deaths in high-risk patients by about 70%. And when given to an exposed person -- like someone living with an infected person -- monoclonal antibodies reduced their risk of developing an infection with symptoms by 80%. The drugs work whether a person is vaccinated or not. As worker and supply shortages continue to strain the economy, can the administration continue to call for the firing of people who are opposed to the mandates? Click below to vote in the poll.